Revolution Medicines (RVMD) Superinvestor holders
20 of the superinvestors we track hold Revolution Medicines (RVMD) in their latest 13F filings, $3.6B in total.
Summary
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $2.5B, 15.0% of the portfolio.
In their latest quarter: 1 opened a new position, 6 added, 13 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Trimmed | 13,550,796 | $2.5B | 15.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 1,359,269 | $255M | 0.6% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 1,295,450 | $243M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 737,697 | $138M | 0.1% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
Added | 399,587 | $75M | 1.7% | Q2 2026 |
| Jennison Associates | Trimmed | 280,933 | $53M | 0.0% | Q2 2026 |
| Baillie Gifford Baillie Gifford & Co |
Trimmed | 254,114 | $52M | 0.0% | Q3 2026 |
| Alger Fred Alger Management |
Added | 259,468 | $49M | 0.2% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 244,544 | $46M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 173,439 | $32M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 134,686 | $28M | 0.0% | Q3 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 120,702 | $23M | 0.1% | Q2 2026 |
| Louis Bacon Moore Capital Management |
Added | 81,700 | $15M | 0.4% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 60,276 | $11M | 0.0% | Q2 2026 |
| WCM Investment Management | Trimmed | 58,074 | $11M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 25,038 | $5M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 16,000 | $3M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Added | 12,500 | $2M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 12,400 | $2M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 4,883 | $914,489 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 20 |
| Q1 2026 | 23 |
| Q4 2025 | 19 |
| Q3 2025 | 16 |
| Q2 2025 | 15 |
| Q1 2025 | 12 |
| Q4 2024 | 13 |
| Q3 2024 | 14 |
Questions about Revolution Medicines
Which superinvestors own Revolution Medicines?
20 of the superinvestors we track hold Revolution Medicines (RVMD) in their latest 13F filings, $3.6B in total. Tom Steyer, Brandon Haley, Cliff Asness, Two Sigma, Stanley Druckenmiller, Jennison Associates.
Who is the largest superinvestor holder of RVMD?
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $2.5B, 15.0% of the portfolio.
From Revolution Medicines's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.